Double-blind Placebo-controlled Dose-ranging Study for the Assessment of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Ascending Oral Doses of GLPG0634 in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 14 Feb 2015
At a glance
- Drugs Filgotinib (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- 23 Mar 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 19 Nov 2010 Status changed from active, no longer recruiting to recruiting.
- 10 Aug 2010 Official title, actual initiation date (1 Aug 2010), planned end date (1 Jun 2011 ) added as reported by ClinicalTrials.gov.